Suppr超能文献

检测和分析泪道阻塞患者泪液中的细胞因子。

Detection & analysis of inflammatory cytokines in tears of patients with lacrimal duct obstruction.

机构信息

Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, P.R. China.

Department of Ophthalmology, Medical College, Wuhan University of Science & Technology, Wuhan, P.R. China.

出版信息

Indian J Med Res. 2021 Jun;154(6):888-894. doi: 10.4103/ijmr.IJMR_1435_19.

Abstract

BACKGROUND & OBJECTIVES: Tear proteomic changes can be a candidate etiopathogenesis of lacrimal duct obstruction diseases (LDODs). Studies on proteomics have focused primarily on nasolacrimal duct obstruction, and some specific inflammatory cytokines such as interferon (IFN)-α2a, interleukin (IL)-8 and IL-10, have not been investigated. In addition, differences in inflammatory cytokines in tears according to the LDOD subtype have not been reported. This study aimed to quantitatively compare inflammatory cytokines in tears from patients with LDOD and investigate tear-cytokine differences among different LDOD subtypes.

METHODS

Tear samples were collected from both eyes of 30 patients with unilateral LDOD: five patients with prelacrimal obstruction, five with acute dacryocystitis and 20 with chronic dacryocystitis. The contralateral eyes were used as controls. IFN-α2a, IFN-β, IFN-γ, IL-17A, IL-6, IL-8, tumour necrosis factor-alpha (TNF-α), vascular endothelial growth factor (VEGF)-A, induced protein-10 (IP-10) and monocyte chemotactic protein-1 (MCP-1) were quantified in all samples.

RESULTS

The expression of eight cytokines (except for IP-10 and MCP-1) were significantly increased in the affected eyes compared with those in the control eyes. The levels of nine inflammatory cytokines (except for IP-10) in the affected eyes of patients with chronic dacryocystitis were higher than those in the affected eyes of patients with prelacrimal obstruction. In addition, patients with chronic dacryocystitis presented significantly higher IFN-γ level than those with prelacrimal obstruction or acute dacryocystitis.

INTERPRETATION & CONCLUSIONS: Specific pro-inflammatory cytokines were increased in tears of patients with LDOD compared with those in the controls. The specific cytokine profiles observed in the tears of individuals with different LDOD subtypes may be associated with the unique aetiopathogenesis of these conditions.

摘要

背景与目的

泪液蛋白质组的变化可能是泪道阻塞性疾病(LDOD)的候选发病机制。蛋白质组学研究主要集中在鼻泪管阻塞上,而干扰素(IFN)-α2a、白细胞介素(IL)-8 和 IL-10 等一些特定的炎症细胞因子尚未得到研究。此外,不同 LDOD 亚型的泪液中炎症细胞因子的差异尚未报道。本研究旨在定量比较 LDOD 患者的泪液中炎症细胞因子,并探讨不同 LDOD 亚型之间的泪液细胞因子差异。

方法

收集 30 例单侧 LDOD 患者(前泪小管阻塞 5 例,急性泪囊炎 5 例,慢性泪囊炎 20 例)双眼的泪液样本。对侧眼作为对照。定量检测所有样本中 IFN-α2a、IFN-β、IFN-γ、IL-17A、IL-6、IL-8、肿瘤坏死因子-α(TNF-α)、血管内皮生长因子(VEGF)-A、诱导蛋白-10(IP-10)和单核细胞趋化蛋白-1(MCP-1)。

结果

与对照组相比,受影响眼中有 8 种细胞因子(除 IP-10 和 MCP-1 外)的表达显著增加。慢性泪囊炎患者受影响眼中的 9 种炎症细胞因子(除 IP-10 外)水平均高于前泪小管阻塞患者。此外,慢性泪囊炎患者的 IFN-γ水平明显高于前泪小管阻塞或急性泪囊炎患者。

解释与结论

与对照组相比,LDOD 患者的泪液中特定的促炎细胞因子增加。不同 LDOD 亚型个体的泪液中观察到的特定细胞因子谱可能与这些疾病的独特发病机制有关。

相似文献

1
Detection & analysis of inflammatory cytokines in tears of patients with lacrimal duct obstruction.
Indian J Med Res. 2021 Jun;154(6):888-894. doi: 10.4103/ijmr.IJMR_1435_19.
5
Cytokine Profiles of Tear Fluid From Patients With Pediatric Lacrimal Duct Obstruction.
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):252-256. doi: 10.1167/iovs.16-20717.
6
Surfactant proteins: Role in lacrimal drainage disorders.
Med Hypotheses. 2019 Mar;124:35-36. doi: 10.1016/j.mehy.2019.01.020. Epub 2019 Jan 24.
7
Lacrimal Fossa Bony Changes in Chronic Primary Acquired Nasolacrimal Duct Obstruction and Acute Dacryocystitis.
Curr Eye Res. 2021 Aug;46(8):1132-1136. doi: 10.1080/02713683.2021.1891254. Epub 2021 Mar 1.
8
Tear protein analysis in patients with primary acquired nasolacrimal duct obstruction treated with lacrimal passage intubation.
Jpn J Ophthalmol. 2021 May;65(3):409-415. doi: 10.1007/s10384-020-00804-6. Epub 2021 Jan 7.
9
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Curr Eye Res. 2020 Sep;45(9):1101-1106. doi: 10.1080/02713683.2020.1715445. Epub 2020 Jan 24.
10
Pathological changes of the nasolacrimal duct in rabbit models of chronic dacryocystitis: correlation with lacrimal endoscopic findings.
Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2103-2112. doi: 10.1007/s00417-018-4129-z. Epub 2018 Sep 5.

引用本文的文献

1
A preliminary study on the clinical characteristics of lacrimal duct obstruction in patients with a history of anterior uveitis.
Front Med (Lausanne). 2025 Jul 4;12:1630425. doi: 10.3389/fmed.2025.1630425. eCollection 2025.
2
Tear Proteome Analysis with Patients with Primary Nasolacrimal Duct Obstruction.
Int J Mol Sci. 2025 Jul 4;26(13):6449. doi: 10.3390/ijms26136449.
5
Bibliometric and visualized analysis of research hotpots and future prospects in lacrimal duct obstruction disease (1900 to 2024).
Int J Ophthalmol. 2025 Mar 18;18(3):526-540. doi: 10.18240/ijo.2025.03.21. eCollection 2025.
6
Anatomic characteristics of the lacrimal sac and adjacent bony structures-a computed tomographic-dacryocystography research.
Int J Ophthalmol. 2025 Feb 18;18(2):251-257. doi: 10.18240/ijo.2025.02.08. eCollection 2025.
7
Authors' response.
Indian J Med Res. 2023 Sep;158(3):318. doi: 10.4103/0971-5916.386666.
8
Inflammatory cytokines in tears of patients with lacrimal duct obstruction.
Indian J Med Res. 2023 Sep;158(3):317. doi: 10.4103/ijmr.ijmr_1487_22.
9
Type 1-type 2 interferon imbalance in dry eye disease.
Indian J Ophthalmol. 2023 Apr;71(4):1526-1532. doi: 10.4103/IJO.IJO_2842_22.

本文引用的文献

1
Tear protein analysis in patients with primary acquired nasolacrimal duct obstruction treated with lacrimal passage intubation.
Jpn J Ophthalmol. 2021 May;65(3):409-415. doi: 10.1007/s10384-020-00804-6. Epub 2021 Jan 7.
2
Best treatments available for distal acquired lacrimal obstruction: A systematic review and meta-analysis.
Clin Otolaryngol. 2020 Jul;45(4):545-557. doi: 10.1111/coa.13551. Epub 2020 May 6.
4
Prolactin and Prolactin-inducible protein (PIP) in the pathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
Med Hypotheses. 2019 Apr;125:137-138. doi: 10.1016/j.mehy.2019.02.051. Epub 2019 Mar 1.
5
Etiopathogenesis of Primary Acquired Nasolacrimal Duct Obstruction: What We Know and What We Need to Know.
Ophthalmic Plast Reconstr Surg. 2019 Sep/Oct;35(5):426-433. doi: 10.1097/IOP.0000000000001310.
7
CD8 T cells and IFN-γ induce autoimmune myelofibrosis in mice.
J Autoimmun. 2018 May;89:101-111. doi: 10.1016/j.jaut.2017.12.011. Epub 2018 Jan 4.
8
Cytokine Profiles of Tear Fluid From Patients With Pediatric Lacrimal Duct Obstruction.
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):252-256. doi: 10.1167/iovs.16-20717.
9
Tear-Film Osmolarity Changes Following Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction.
Curr Eye Res. 2017 Mar;42(3):348-350. doi: 10.1080/02713683.2016.1196706. Epub 2016 Jul 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验